We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News   May 11, 2021

 
FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Credit: Shaun F/ Pixabay

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Kits by Izon Science Standardize Extracellular Vesicle Concentration and EV-RNA Extraction

Product News

Izon Science Ltd, the manufacturer of nano-biological separation and characterization tools, announced today the release of two new kits: the qEV Concentration Kit for the isolation and concentration of extracellular vesicles (EVs), and the qEV RNA Extraction Kit, which enables the extraction of RNA from EVs.

READ MORE

Sphere Fluidics and ClexBio Introduce CYTRIX Microfluidic Hydrogel Kit

Product News

Sphere Fluidics and ClexBio have announced the launch of the biocompatible CYTRIX Microfluidic Hydrogel Kit.

READ MORE

Foresight Diagnostics Completes Series A Financing To Accelerate Minimal Residual Disease Technology

Product News

Foresight Diagnostics has announced the close of its $12.5M Series A financing to commercialize the minimal residual disease (MRD) detection assay.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE